Oxford Cannabinoid Technologies’ deal for exclusive access to Canopy Growth’s cannabinoid library

Share on facebook
Share on twitter
Share on linkedin
Share on email

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, FRA:0CB) (OCT) chief executive, Dr John Lucas, talks to Proactive London’s Katie Pilbeam about news of a licensing deal with Canopy Growth, one of the world’s largest cannabis companies.

As Lucas explains, under the deal they have exclusive access to Canopy’s entire cannabinoid derivative library. This includes 335 derivatives of cannabidiol (CBD), tetrahydrocannabinol (THC) and cannabigerol (CBG) and intellectual property rights, including 14 patent families and “associated product research and development”.

View original source video by clicking here

On Key

Related Posts

Cannabis Industry Fire Safety

Cannabis Growing & Processing Fire Protection The cannabis industry has gone through a rapid expansion and with the expansion comes an increase in Read more